Major bleeding complications and persistence with oral anticoagulation in non‐valvular atrial fibrillation: contemporary findings in real‐life Danish patients

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - Am Heart Assoc
Background The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - research.regionh.dk
BACKGROUND: The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

[HTML][HTML] Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish …

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - ncbi.nlm.nih.gov
Background The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: Contemporary findings in real-life Danish patients

M Lamberts, L Staerk, JB Olesen, EL Fosbøl… - core.ku.dk
Background-The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

[PDF][PDF] Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

M Lamberts, L Staerk, JB Olesen, EL Fosbøl… - 2017 - core.ac.uk
Background-—The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

[PDF][PDF] Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

M Lamberts, L Staerk, JB Olesen, EL Fosbøl… - 2017 - pdfs.semanticscholar.org
Background-—The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: Contemporary findings in real-life Danish patients

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - portal.findresearcher.sdu.dk
Background-The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients

M Lamberts, L Staerk, JB Olesen, EL Fosbøl… - Journal of the American …, 2017 - cir.nii.ac.jp
抄録< jats: sec xml: lang=" en">< jats: title> Background</jats: title>< jats: p xml: lang=" en">
The nonvitamin K antagonist oral anticoagulants have recently become available as an …

Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: Contemporary findings in real-life Danish patients

M Lamberts, L Staerk, JB Olesen, EL Fosbøl… - comm.ku.dk
Background-The nonvitamin K antagonist oral anticoagulants have recently become
available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on …